Phibro Animal Health Corp reports results for the quarter ended June 30 - Earnings Summary
Phibro Animal Health Corp reports results for the quarter ended June 30 - Earnings Summary
Phibro Animal Health Corp PAHC.OQ reported quarterly adjusted earnings of 85 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 57 cents. The mean expectation of five analysts for the quarter was for earnings of 71 cents per share. Wall Street expected results to range from 66 cents to 75 cents per share.
Revenue rose 4.8% to $396.70 million from a year ago; analysts expected $381.25 million.
Phibro Animal Health Corp's reported EPS for the quarter was 53 cents.
The company reported quarterly net income of $21.7 million.
Phibro Animal Health Corp shares had risen by 14.4% this quarter and lost 3.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is "buy."
Wall Street's median 12-month price target for Phibro Animal Health Corp is $41.50, about 13% above its last closing price of $36.09
This summary was machine generated from LSEG data August 26 at 10:17 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.71 | 0.85 | Beat |
Mar. 31 2026 | 0.71 | 0.76 | Beat |
Dec. 31 2025 | 0.67 | 0.87 | Beat |
Sep. 30 2025 | 0.62 | 0.73 | Beat |
Recent news on Phibro Animal Health
See all newsPhibro Animal Health Corp reports results for the quarter ended June 30 - Earnings Summary
Phibro Animal Health Q4 results beat estimates on mineral nutrition growth
Phibro Animal Health Q3 sales and profit beat estimates
Phibro Animal Health Q2 revenue beats estimates on vaccine demand
Brief: Phibro Animal Health Q2 Adjusted EBITDA USD 68.1 Million